000 01256 a2200337 4500
005 20250517200128.0
264 0 _c20180507
008 201805s 0 0 eng d
022 _a1473-5741
024 7 _a10.1097/CAD.0000000000000591
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBayati, Samaneh
245 0 0 _aAntileukemic effects of neurokinin-1 receptor inhibition on hematologic malignant cells: a novel therapeutic potential for aprepitant.
_h[electronic resource]
260 _bAnti-cancer drugs
_c03 2018
300 _a243-252 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAprepitant
650 0 4 _aCell Line, Tumor
650 0 4 _aHematologic Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMorpholines
_xpharmacology
650 0 4 _aNeurokinin-1 Receptor Antagonists
_xpharmacology
650 0 4 _aReceptors, Neurokinin-1
_xmetabolism
700 1 _aRazani, Elham
700 1 _aBashash, Davood
700 1 _aSafaroghli-Azar, Ava
700 1 _aSafa, Majid
700 1 _aGhaffari, Seyed H
773 0 _tAnti-cancer drugs
_gvol. 29
_gno. 3
_gp. 243-252
856 4 0 _uhttps://doi.org/10.1097/CAD.0000000000000591
_zAvailable from publisher's website
999 _c28033471
_d28033471